Percentages of human CD45, CD19, CD11b, and CD34 in BM, spleen, and blood of animals 12 weeks after cotransplantation of 1 × 105 hUCB CD34+ cells and 1 × 106 expanded Stro-1+ or Stro-1− cells in NOD/SCID mice
Tissue . | CD34+ Stro-1− . | CD34+ Stro-1+ . | CD34+ . |
|---|---|---|---|
| BM | |||
| CD45 | 48 ± 22 | 33 ± 16 | 27 ± 25 |
| CD19 | 38 ± 13 | 21 ± 13 | 20 ± 17 |
| CD11b | 3 ± 1 | 4 ± 1 | 3 ± 3 |
| CD34 | 9 ± 3 | 5 ± 2 | 4 ± 4 |
| Spleen | |||
| CD45 | 35 ± 25 | 14 ± 8 | 15 ± 16 |
| CD19 | 19 ± 23 | 7 ± 6 | 11 ± 12 |
| CD11b | 8 ± 10 | 0.8 ± 0.7 | 3 ± 4 |
| Blood | |||
| CD45 | 14 ± 12 | 3 ± 2 | 4 ± 4 |
| CD19 | 9 ± 7 | 1.6 ± 1.3 | 3 ± 3 |
| CD11b | 4 ± 6 | 0.25 ± 0.25 | 1 ± 1 |
Tissue . | CD34+ Stro-1− . | CD34+ Stro-1+ . | CD34+ . |
|---|---|---|---|
| BM | |||
| CD45 | 48 ± 22 | 33 ± 16 | 27 ± 25 |
| CD19 | 38 ± 13 | 21 ± 13 | 20 ± 17 |
| CD11b | 3 ± 1 | 4 ± 1 | 3 ± 3 |
| CD34 | 9 ± 3 | 5 ± 2 | 4 ± 4 |
| Spleen | |||
| CD45 | 35 ± 25 | 14 ± 8 | 15 ± 16 |
| CD19 | 19 ± 23 | 7 ± 6 | 11 ± 12 |
| CD11b | 8 ± 10 | 0.8 ± 0.7 | 3 ± 4 |
| Blood | |||
| CD45 | 14 ± 12 | 3 ± 2 | 4 ± 4 |
| CD19 | 9 ± 7 | 1.6 ± 1.3 | 3 ± 3 |
| CD11b | 4 ± 6 | 0.25 ± 0.25 | 1 ± 1 |